|
Policy and Research Needs to Maximize Independence and Support Community Living-A Workshop
|
Meeting/ Workshop
|
ACL, CMS, FDA
|
NHLBI, NIA
|
Identify and discuss policies that catalyze innovation Identify how to improve care coordination and facilitate community integration Explore research and policy gaps and needs Determine current state of integration of service delivery and finance.
|
|
Polyhalogenated Aromatic Hydrocarbons (PHAH) and Thyroid Cancer
|
Research Initiative
|
CDC
|
NCI
|
Polyhalogenated aromatic hydrocarbons are being measured in banked serum/plasma samples from cohort studies to evaluate the association with thyroid cancer incidence.
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
The Population Assessment of Tobacco and Health (PATH) Study is the first large-scale National Institutes of Health (NIH)/U.S. Food and Drug Administration (FDA) collaboration since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009. The PATH Study is a national longitudinal cohort study that will follow an estimated 59,000 U.S. household residents ages 12 years and older for at least three years. Objectives are to assess initiation and use patterns; to study trends in tobacco-product use cessation and relapse; to monitor behavioral and health impacts, including in risk perceptions and other tobacco-related attitudes; and to assess differences in tobacco-related attitudes, behaviors, and health outcomes among racial/ethnic, gender, and age subgroups. The PATH Study will also collect biospecimens from adults to analyze biomarkers of tobacco use and related health outcomes. By measuring and accurately reporting on the social, behavioral, and health effects associated with tobacco-product use in the U.S., the PATH Study will provide an empirical evidence base to help inform FDA’s decisions about changes in tobacco products in meeting the objectives of the 2009 FSPTCA.
|
|
Post-traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI) Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIMH, NIAAA, NIDA, NINDS
|
A 2012 White House Executive Order, emphasizing support of Service Members, Veterans, and their families as a "top priority," called for an urgent increase in the Departments of Health and Human Services (HHS), Defense (DoD), and Veterans Affairs (VA) research coordination to address the problems of PTSD, TBI, and suicide. Section 5 of this Executive Order requested a National Research Action Plan (NRAP) to develop biomarkers, define the pathophysiology, and develop new treatments for PTSD. HHS charged NIMH to lead this effort along with a parallel effort for TBI led by NINDS, with both Institutes working closely with VA and DoD. In 2013, the NRAP was released in response to the Executive Order. Prior investments integrating the molecular, genomic, and brain circuitry changes that give rise to PTSD in the context of environmental factors provide the requisite foundation to respond to this White House request for biomarkers for risk prediction, as well as new targets for medications, and other therapies to treat PTSD. This investment has the potential to revolutionize the care for individuals at high risk for PTSD and prevent the development of chronic complex treatment-resistant PTSD. Additionally, in 2014, the White House and the Office of Management and Budget created a Cross Agency Priority Goal (CAP-G) to improve mental health outcomes for Service Members, Veterans, and their families. To achieve this goal, HHS (NIH), VA, and DoD are supporting research that will standardize and integrate measurements for TBI, PTSD, and suicide prevention research funded by the agencies. Also, the PTSD/TBI workgroup is tasked to develop and test suicide risk assessments and suicide prevention, and treatment interventions for Service Members and Veterans. The agencies meet weekly on these efforts and report quarterly on progress.
|
|
Postpartum Initiative/Conference
|
Meeting/ Workshop
|
CDC, HRSA
|
NICHD, NIMH
|
In FY2015 NICHD has been working on a Postpartum Depression initiative/conference that is due to launch in FY2016. The National Child and Maternal Health Education Program (NCMHEP) is currently working on a Postpartum Depression initiative for its next topic area. The NCMHEP Coordinating Committee is made up of 32 organizations including HHS agencies (CDC, OMH, ORWH, OWH, and MCHB) This initiative will include print materials and a social media component. We will also be using a video that was produced by NIMH on postpartum depression. The initiative is focused on raising awareness amongst pregnant women and their families about PPD. We want them to know that PPD has more than just depression symptoms and it can occur during pregnancy and in the postpartum period through the first year of the child’s life. Also that it not uncommon and that there is help and treatment so women do not need to suffer in silence. The initiative has a tentative launch date of January 2016.
|
|
Practical Oral Care for People with Developmental Disabilities
|
Public Education Campaign
|
CDC
|
NIDCR, NICHD
|
A series of publications designed to equip dental professionals in the community with the information they need to deliver quality oral health care to people with special needs.
|
|
Practice-Based Research and Implementation: Developing a Framework for Collaboration to Reduce Mental Health Disparities
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
NIMH and the Substance Abuse and Mental Health Services Administration (SAMHSA) host an annual webinar to enhance understanding of the development of collaborative approaches to behavioral health services. These collaborative efforts will accelerate the dissemination of research-based material and treatment information to communities. These conversations will identify ways to align ongoing efforts to address disparities in mental health outcomes across diverse populations. The information resulting from this discussion will be used to develop an action plan and help to enhance the partnership between NIMH and SAMHSA.
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
This project addresses key regulatory considerations relevant to using bacteriophages for decolonization of the drug-resistant nosocomial pathogens, vancomycin-resistant enterococci (VRE) and methicillin-resistant staphylococcus aureus (MRSA). These include characterizing pathogen resistance to phage, defining phage mixtures ("cocktails") to circumvent resistance, optimizing mouse models to evaluate pathogen decolonization and identifying endpoints that support claims for clinical benefit (e.g., reduced risk of disease transmission).
|
|
PregSource Management Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, HRSA
|
NICHD, NCCIH, NHLBI, NIEHS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH
|
In consultation with the PregSource Partners, the PregSource Management Team:
• Finalizes selection of topics for inquiry
• Works closely with PregSource contractor to develop site
• Assures compliance with applicable NIH policies and procedures, including IRB approval
• Develops content for online and app-based versions
• Oversees outreach efforts to bolster participation
• Monitors overall function and usage of PregSource
• Participates in analysis and interpretation of data
• Reports results in publications and presentations
|
|
President''s Commission on the Study of Bioethical Issues
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
Christine Grady participates as a Commissioner on the Presidential Commission for the Study of Bioethical Issues. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The Commission undertakes study of issues presented to them by the President and the Secretary of Health and Human Services.
|